Korean J Pediatr Infect Dis.  1999 Nov;6(2):239-244. 10.14776/kjpid.1999.6.2.239.

An Outbreak of Mumps in Taejon, Korea, 1998

• Kang HD
• Lee KY
• Cha SW
• Yoon KN
• Lee DJ
• Han JW
• Hang JH
• Whang KT

• KMID: 2440262
• DOI: http://doi.org/10.14776/kjpid.1999.6.2.239

Abstract

PURPOSE
In 1998, there was an outbreak of mumps in Taejon, Korea. We analyzed the monthly incidence, clinical manifestations, and complications during the outbreak and the annual incidence of the recent ten years.
METHODS
We reviewed the clinical records of 35 mumps patients who had been admixed to Taejon St. Mary's Hospital from January to December, 1998.
RESULTS
Mumps was prevalent in summer(from June to August) with 20 cases(57%).Thirthy-three patients(94.3%) received MMR at 15 months of age and no patients received a booster mumps vaccine. The mean age of the mumps patients was 10.5 years-old and the majority of mumps(71%) occurred between 5 and 12 year of age. The male female ratio was 2.2 : 1. The clinical manifestations were swelling of carotid gland(100%), fever (91%), vomiting(77%), abdominal pain(74%) and headache(66%) in order of frequency. Meningitis occurred in 20 cases(57%) and the mean WBC count of CSF was 464±263/mm³. In serology, the mean serum amylase level was 483±2941U/dL and anti-mumps IgM and IgG were positive in 11 and 15 out of 18 cases, respectively. From 1989 to 1997, the mean mumber of inpatients with mumps was 3.4 per year.
CONCLUSION
We experienced an outbreak of mumps in 1998. It is suggested that there was a primary mumps vaccine failure in Korea and that father studies for vaccine faiure and method of booster mumps vaccine are necessary.

Keyword

Mumps; Outbreak; 1998

MeSH Terms

Amylases
Daejeon*
Fathers
Female
Fever
Humans
Immunoglobulin G
Immunoglobulin M
Incidence
Inpatients
Korea*
Male
Meningitis
Methods
Mumps Vaccine
Mumps*
Amylases
Immunoglobulin G
Immunoglobulin M
Mumps Vaccine